Search results
New JAK 1 Inhibitor Proves Promising in Phase 3 RA Trial
Medscape· 4 days agoThe highly selective oral Janus kinase (JAK) inhibitor SHR0302 (ivarmacitinib) enables more patients...
UK researchers trial monitoring technology for patients with rheumatoid arthritis
Hospital Management via Yahoo Finance· 3 days ago"UK researchers trial monitoring technology for patients with rheumatoid arthritis" was originally...
Polyarthritis vs. oligoarthritis: Symptoms, causes, and more
Medical News Today· 2 days ago“Polyarthritis” and “oligoarthritis” describe the number of joints involved in arthritic conditions,...
Doctors Test the Limits of What Obesity Drugs Can Fix
New York Times· 5 days ago“Obesity first” doctors say they start with one pill, to treat obesity, and often find other chronic...
Sjogren's Syndrome
Health· 4 days agoTreatments like eye drops and medications can help decrease symptoms, although some may still be bothersome. It’s also important to...Sjogren’s Syndrome...
Shoring up blood vessels may offer new approach for treating autoimmune rheumatic diseases
Medical Xpress· 6 days agoA study from physician-scientists at the Hospital for Special Surgery (HSS) points to a potential...
Phase 3 Trial Supports Ixekizumab in Juvenile PsA, ERA
Medscape· 3 days agoIxekizumab (Taltz), an interleukin-17A inhibitor that's already approved for the treatment of...
REMORA: New technology is first to allow patients to add daily symptoms to their health record
Medical Xpress· 4 days agoThe Remote Monitoring of Rheumatoid Arthritis (REMORA) system allows patients to download a symptom...
Use This Common Cardiac Test in RA Patients, Study Suggests
MedPage Today· 4 days agoPatients with rheumatoid arthritis (RA) are likely to benefit from regular high-sensitivity cardiac...
Joint pain at night: Causes and treatment
Medical News Today· 4 days agoJoint pain at night has several causes, including a person’s sleeping position, bedding used, and existing medical conditions, such as arthritis....